×
About 4,762 results

ALLMedicine™ Crohn Disease Center

Research & Reviews  2,333 results

Scrofula associated with a patient receiving adalimumab therapy for Crohn disease.
https://doi.org/10.1111/ced.14434
Clinical and Experimental Dermatology References; Hunt WTN, Wheeler JF et. al.

Sep 15th, 2020 - Scrofula associated with a patient receiving adalimumab therapy for Crohn disease.|2020|Hunt WTN,Wheeler JF,Kennedy NA,Burden T,McGrath EJ,|

Crohn Disease Presenting as the Cutaneous Rash of Pyoderma Gangrenosum.
https://doi.org/10.1097/PEC.0000000000002225
Pediatric Emergency Care; Harris CA, Lehto EM et. al.

Sep 14th, 2020 - Pyoderma gangrenosum (PG) is a rare pediatric diagnosis, occurring in 3 to 10 patients per million per year, and most commonly seen in individuals between ages 20 and 50 years. This severe ulcerating skin rash is typically associated with an under...

Association Between Early Severe Cardiovascular Events and the Initiation of Treatment ...
https://doi.org/10.1001/jamadermatol.2020.2977
JAMA Dermatology; Poizeau F, Nowak E et. al.

Sep 9th, 2020 - Ustekinumab, a monoclonal antibody targeting interleukin 12/23p40 (IL-12/23p40), is effective in the treatment of moderate to severe psoriasis, psoriatic arthritis, and Crohn disease. In 2011, a meta-analysis of randomized clinical trials reported...

Inflammatory Bowel Diseases Elevate the Risk of Developing Acute Pancreatitis: A Meta-a...
https://doi.org/10.1097/MPA.0000000000001650
Pancreas Tél B, Stubnya B et. al.

Sep 8th, 2020 - Increasing data suggest that acute pancreatitis (AP) occurs more frequently among patients with inflammatory bowel diseases (IBDs) than in the non-IBD population; however, currently no comprehensive meta-analysis is available. Systematic literatur...

Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outco...
https://doi.org/10.1093/ibd/izaa219
Inflammatory Bowel Diseases; Albshesh A, Ungar B et. al.

Aug 28th, 2020 - Mucosal healing has been associated with long-term response to therapy for Crohn disease (CD). However, little is known about the significance of terminal ileum (TI) transmural thickness in predicting clinical outcomes. In this retrospective obser...

see more →

Guidelines  19 results

ACR Appropriateness Criteria® Crohn Disease.
https://doi.org/10.1016/j.jacr.2020.01.030
Journal of the American College of Radiology : JACR; , Kim DH et. al.

May 5th, 2020 - Three common clinical scenarios involving use of imaging in Crohn disease are covered. These include the initial evaluation of Crohn disease when the diagnosis has not been previously established, the evaluation for anticipated exacerbation of kno...

European Society of Paediatric Radiology abdominal imaging task force: statement on ima...
https://doi.org/10.1007/s00247-019-04375-8
Pediatric Radiology; Watson TA, Petit P et. al.

Mar 27th, 2019 - Very early onset inflammatory bowel disease (VEO-IBD) is defined as disease presenting before the age of 6. These children require a tailored imaging approach because conventional imaging studies can be difficult to perform at such a young age. Un...

Antibiotics for induction and maintenance of remission in Crohn's disease
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012730.pub2/full
Townsend,C.,et al

Feb 6th, 2019 - Moderate to high quality evidence suggests that any benefit provided by antibiotics in active CD is likely to be modest and may not be clinically meaningful. High quality evidence suggests that there is no increased risk of adverse events with ant...

Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases—A Clinical Pr...
https://www.gastrojournal.org/article/S0016-5085(18)34933-3/fulltext
Hanauer, S.,et al

Jan 22nd, 2019 - Thiopurines (azathioprine, mercaptopurine, thioguanine) and methotrexate are widely used in a variety of clinical management scenarios for ulcerative colitis and Crohn's disease. With the introduction of biologic therapies over the last 2 decades,.

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children
https://journals.lww.com/jpgn/Fulltext/2019/01000/Fecal_Microbiota_Transplantation_for_Recurrent.25.aspx
Davidovics,Z.,et al

Jan 21st, 2019 - Fecal microbiota transplantation (FMT) is becoming part of the treatment algorithms against recurrent Clostridium difficile infection (rCDI) both in adult and pediatric gastroenterology practice. With our increasing recognition of the critical rol...

see more →

Drugs  9 results see all →

Clinicaltrials.gov  2,359 results

Scrofula associated with a patient receiving adalimumab therapy for Crohn disease.
https://doi.org/10.1111/ced.14434
Clinical and Experimental Dermatology References; Hunt WTN, Wheeler JF et. al.

Sep 15th, 2020 - Scrofula associated with a patient receiving adalimumab therapy for Crohn disease.|2020|Hunt WTN,Wheeler JF,Kennedy NA,Burden T,McGrath EJ,|

Crohn Disease Presenting as the Cutaneous Rash of Pyoderma Gangrenosum.
https://doi.org/10.1097/PEC.0000000000002225
Pediatric Emergency Care; Harris CA, Lehto EM et. al.

Sep 14th, 2020 - Pyoderma gangrenosum (PG) is a rare pediatric diagnosis, occurring in 3 to 10 patients per million per year, and most commonly seen in individuals between ages 20 and 50 years. This severe ulcerating skin rash is typically associated with an under...

Association Between Early Severe Cardiovascular Events and the Initiation of Treatment ...
https://doi.org/10.1001/jamadermatol.2020.2977
JAMA Dermatology; Poizeau F, Nowak E et. al.

Sep 9th, 2020 - Ustekinumab, a monoclonal antibody targeting interleukin 12/23p40 (IL-12/23p40), is effective in the treatment of moderate to severe psoriasis, psoriatic arthritis, and Crohn disease. In 2011, a meta-analysis of randomized clinical trials reported...

Inflammatory Bowel Diseases Elevate the Risk of Developing Acute Pancreatitis: A Meta-a...
https://doi.org/10.1097/MPA.0000000000001650
Pancreas Tél B, Stubnya B et. al.

Sep 8th, 2020 - Increasing data suggest that acute pancreatitis (AP) occurs more frequently among patients with inflammatory bowel diseases (IBDs) than in the non-IBD population; however, currently no comprehensive meta-analysis is available. Systematic literatur...

Terminal Ileum Thickness During Maintenance Therapy Is a Predictive Marker of the Outco...
https://doi.org/10.1093/ibd/izaa219
Inflammatory Bowel Diseases; Albshesh A, Ungar B et. al.

Aug 28th, 2020 - Mucosal healing has been associated with long-term response to therapy for Crohn disease (CD). However, little is known about the significance of terminal ileum (TI) transmural thickness in predicting clinical outcomes. In this retrospective obser...

see more →

News  41 results

Vulvar and gluteal manifestations of Crohn disease
https://www.mdedge.com/ccjm/article/208585/womens-health/vulvar-and-gluteal-manifestations-crohn-disease?channel=162
Anna Camille Moreno, DO, NCMP, Oluwatosin Goje, MD, MSCR, FACOG et. al.

Oct 1st, 2019 - A 37-year-old woman presented with recurring painful swelling and erythema of the vulva over the last year. Despite a series of negative vaginal cultures, she was prescribed multiple courses of antifungal and antibacterial treatments, while her sy.

Antibiotics for induction and maintenance of remission in Crohn's disease
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012730.pub2/full
Townsend,C.,et al

Feb 6th, 2019 - Moderate to high quality evidence suggests that any benefit provided by antibiotics in active CD is likely to be modest and may not be clinically meaningful. High quality evidence suggests that there is no increased risk of adverse events with ant...

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children
https://journals.lww.com/jpgn/Fulltext/2019/01000/Fecal_Microbiota_Transplantation_for_Recurrent.25.aspx
Davidovics,Z.,et al

Jan 21st, 2019 - Fecal microbiota transplantation (FMT) is becoming part of the treatment algorithms against recurrent Clostridium difficile infection (rCDI) both in adult and pediatric gastroenterology practice. With our increasing recognition of the critical rol...

Metastatic Vulvovaginal Crohn Disease in the Setting of Well-Controlled Intestinal Disease
https://www.mdedge.com/dermatology/article/173330/urticaria/metastatic-vulvovaginal-crohn-disease-setting-well-controlled/page/0/1

Aug 24th, 2018 - Comment Crohn disease is an idiopathic chronic inflammatory condition that primarily affects the gastrointestinal tract, anywhere from the mouth to the anus. It is characterized by transmural inflammation and fissures that can extend beyond the mu.

Clinical Practice Snapshot: Incorporating Janus Kinase Inhibitors Into the Management of Rheumatoid Arthritis CME/CE AMA PRA Category 1 Credits™
https://www.mdedge.com/rheumatology/article/172293/clinical-practice-snapshot-incorporating-janus-kinase-inhibitors

Aug 9th, 2018 - In 1998, the US Food and Drug Administration (FDA) approved infliximab for the treatment of Crohn disease, marking the dawn of the biologic era in inflammatory diseases ( Figure 1 ). A few months later, etanercept became the first tumor necrosis f.

see more →

Patient Education  1 results see all →